LOS ANGELES–(BUSINESS WIRE)–A recently published study of thousands of fibromyalgia patients illuminates a pathway to preventing the life-threatening pneumonia, lung damage and immunologic complications that can be caused by a COVID-19 infection, according to EpicGenetics Inc., which funded and conducted the research with the University of Illinois College of Medicine at Chicago’s Department of Pathology. The peer-reviewed research, published in the Journal of Advances in Medicine and Medical Research, found that the immune system deficiencies that define a diagnosis of fibromyalgia also limit potentially fatal complications from a COVID-19 infection.
The Research Article can be found here: https://www.businesswire.com/news/home/20210421005573/en/Pathway-to-Prevent-Improve-the-Treatment-of-Deadly-COVID-19-Infections-Revealed-in-EpicGenetics-Funded-Study-of-Thousands-of-Fibromyalgia-Patients
07 281 1481 or 0800 224 787 or Text 022 658 0251
[email protected]
